Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 04, 2025

Get In Touch

FDA Approves Tezspire for Chronic Rhinosinusitis with Nasal Polyps ENT

FDA Approves Tezspire for Chronic Rhinosinusitis with Nasal Polyps

  • 24 October 2025
  • 1 week ago

AstraZeneca Tezspire approved in EU for chronic rhinosinusitis with nasal polyps Pharma News

AstraZeneca Tezspire approved in EU for chronic rhinosinusitis with nasal polyps

  • 23 October 2025
  • 1 week ago

AstraZeneca-Amgen Tezspire gets USFDA nod for chronic rhinosinusitis with nasal polyps Pharma News

AstraZeneca-Amgen Tezspire gets USFDA nod for chronic rhinosinusitis with nasal polyps

  • 18 October 2025
  • 2 weeks ago

AstraZeneca-Amgen Tezspire recommended for approval in EU for chronic rhinosinusitis with nasal polyps Pharma News

AstraZeneca-Amgen Tezspire recommended for approval in EU for chronic rhinosinusitis with nasal polyps

  • 22 September 2025
  • 1 month ago

Tezepelumab Significantly Reduced Asthma Exacerbations: Phase 3 NAVIGATOR Trial Medicine

Tezepelumab Significantly Reduced Asthma Exacerbations: Phase 3 NAVIGATOR Trial

  • 11 July 2025
  • 3 months ago

Recent News

Nanotechnology Reverses Alzheimer's Symptoms in Mi...

  • 03 November, 2025

Gum disease could silently cause serious brain dam...

  • 03 November, 2025

Can Early-Day Fasting Significantly Boost Metaboli...

  • 03 November, 2025

Delhi HC bars doctor from running medical centre d...

  • 03 November, 2025

Phase III data for Gazyva/Gazyvaro show significan...

  • 03 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.